The St. Jude/PIDS Pediatric Infectious Diseases Conference features leaders in the field of Infectious Diseases and features Transplant ID, Original Research, Career Development and Global Health.
For over 20 years, this symposium, hosted by the St. Jude Department of Infectious Diseases and the Pediatric Infectious Diseases Society, has highlighted research as a career for pediatric infectious diseases specialists by drawing from all the Pediatric Infectious Diseases training programs in the country.


Agenda for 2022 Conference
Wednesday, March 2 | Meet and Greet |
---|---|
10:00 a.m.-4:45 p.m. | Meet the Experts
|
Thursday, March 3 | Transplant and Immunocompromised Hosts ID Symposium: Bench to Bedside | |
---|---|---|
7:50 – 8:00 a.m. | Welcome and Announcements Hayley Gans, MD, Stanford University Medical Center Gabriela Maron, MD, St. Jude Children’s Research Hospital |
|
8:00 – 8:55 a.m. | Grand Rounds |
|
9:00 – 9:45 AM | Platform Presentation: Virus-specific T Cells Post Transplant Catherine Bollard, M.D., FRACP, FRCPA, Children’s National Hospital, The George Washington University School of Medicine and Health Sciences (Lecture not recorded) |
|
9:45 – 10:00 AM | Abstract Presentation: Morbidity and Mortality Associated with Respiratory Syncytial Virus (RSV) Among Pediatric Hematopoietic Cell (HCT) and Solid Organ Transplant (SOT) Recipients: Preliminary Results from a Multi-Site U.S. Study |
|
10:00 – 10:15 AM |
BREAK
|
|
10:15 – 11:00 AM | Platform Presentation: Phage Therapy for MDRO and Mycobacteria in Transplant Candidate and Recipients |
|
11:00-11:25 AM | Research Update: PIDS/St Jude Transplant ID Research Working Group Updates: |
|
11:25 – 12:05 PM | Platform Presentation: COVID in Pediatric Immunocompromised Host |
|
12:05-12:35 PM | LUNCH BREAK | |
12:35 PM –2:05 PM | Case Conferences – Cases in Immunocompromised Hosts Moderators: Small but Mighty A Red Herring Don’t Rely on the Gram Stain: Fatal Hyperammonemia Syndrome in Two Immunocompromised Pediatric Patients You Give Me Fever Infectious Complications of HSCT Therapeutics An Uncommon Agent Involved in Soft Tissue Infection in a Child with Leukemia |
|
2:05 – 2:15 PM |
BREAK | |
2:15 – 2:30 PM | Abstract: Gut Decontamination, the Microbiome, and the Risk of Bloodstream Infections During Pediatric Allogeneic Hematopoietic Cell Transplantation |
|
2:30 – 3:10 PM | Interactive Session: Jeopardy |
|
3:15 - 4:00 PM | Platform Presentation: Overview of Transplant Immunology |
|
4:00 – 4:30 PM | BREAK | |
4:30 – 5:30 PM |
Poster Session: Transplant and Research (Nonaccredited) The Transplant and Research Poster Sessions will run simultaneously. |
|
TRANSPLANT POSTERS Moderators: Mike Green, MD, MPH – University of Pittsburgh School of Medicine, Natasha Halasa, MD, MPH – Vanderbilt University Medical Center Variation in Antibiotic Use and Incidence of Surgical Site Infections in Pediatric Liver Transplant Recipients A Multicenter Study Exploring the Epidemiology and Outcomes of COVID-19 Among Pediatric Hematopoietic Cell Transplant, Cellular Therapy and Solid Organ Transplant Recipients: Preliminary Results from the Pediatric COVID-19 U.S. Registry Antibiotic Exposure and Risk of Cytomegalovirus Viremia Among Pediatric Hematopoietic Stem Cell Transplant Recipients at a Single Institution A Retrospective Study of Valganciclovir Discontinuation Due to Toxicity or Intolerance in Pediatric Solid Organ Transplant Patients Pediatric Febrile Neutropenia with Low Risk of Systemic Infection: When Is It Safe to Stop Antibiotics? Manual Validation of an Automated Tool to Extract Blood Culture and Susceptibility Data from the Electronic Health Record for Children with Acute Myeloid Leukemia |
RESEARCH POSTERS Moderator: Buddy Creech, MD – Vanderbilt University Medical Center The highly conserved stem-loop II RNA element (s2m) is critical for the lifecycle of astrovirus VA1 but is dispensable for SARS-CoV-2 Rapid, Non-Invasive Detection of Non-H. pylori Helicobacter Infections in Immunocompromised Children Using Microbial Cell-Free DNA Next Generation Sequencing in Plasma Elucidating key interactions between macrophages and Coccidioides An RSV live-attenuated vaccine candidate lacking G protein mucin domains is highly attenuated, immunogenic, and effective in RSV prevention in BALB/c mice Does Cytomegalovirus (CMV) Status Impact the Host Response to SARS-CoV-2? Resolution of thrombocytopenia during treatment for symptomatic congenital cytomegalovirus disease Nasal microbiota differences in young infants are associated with early childhood irritability |
Friday, March 4 | Pediatric Infectious Diseases Research Symposium |
---|---|
7:55-8:00 AM | Welcome and Announcements Elaine Tuomanen, MD, St. Jude Children’s Research Hospital C. Buddy Creech, MD, MPH, Vanderbilt University Medical Center |
8:00 – 8:45 AM | Frontier Lecture: Contrasting MIS-C and Kawasaki Disease |
8:45 – 9:00 AM |
Abstract: Single Cell RNA Sequencing of Zika Infection in Neural Tissues Reveals an Astrocyte-Driven Innate Immune Response Governed by Interferon Beta |
9:00 – 9:45 AM | Keynote Address: Why Did My Patient Die? Answers from the Pneumococcal Surface |
9:45 – 10:00 AM | BREAK |
10:00 – 10:45 AM | Frontier Lecture: Learning From the Human Adaptive Immune Response to Staphylococcus aureus Infections |
10:45 – 11:00 AM | Abstract: COVID-19 among pediatric patients with pre-existing pulmonary conditions: Preliminary results from the Pediatric COVID-19 U.S. Registry |
11:00 – 11:45 AM | Frontier Lecture: Understanding and Predicting Biotic and Abiotic Perturbations to Developing Pediatric Microbiomes Gautam Dantas, PhD, Washington University School of Medicine (Lecture not recorded) |
11:45 - 12:00 PM | BREAK |
11:30 AM – 12:30 PM | 2022 John H. Erskine Lecture in Infectious Diseases Antibody and Vaccine Mediated Protection to Emerging SARS-CoV-2 Variants |
1:00 – 1:15 PM | LUNCH BREAK |
1:15 – 2:00 PM | Career Paths Breakout Discussion Looking for a Job K-award Session Talking to the Media |
2:00 – 2:15 PM | BREAK |
2:15 – 2:30 PM | Abstract: Viral DNAemia and Viral Seropositivity are Associated with Mortality in Pediatric Patients with Severe Sepsis |
2:30 – 3:15 PM | Luminary in Pediatric Infectious Diseases My Journey in Pediatric Infectious Diseases: More Than “a Little Help from my Friends” |
3:15 – 3:30 PM | Abstract: Development of a Kinetic ELISA (kELISA) and Reactive B Cell Frequency (RBF) Assay to Detect Respiratory Syncytial Virus (RSV) Pre-Fusion F Protein-Specific Immune Responses in Infants |
3:30 – 4:00 PM | Career Development Presentation The Value of Diversity in the Pediatric Infectious Disease Research Workforce |
4:00 – 5:30 PM | Career Development Session
|
5:30 p.m. | CLOSING REMARKS |
Saturday, March 5 | Global Health Symposium |
---|---|
8:00 – 8:05 AM | Welcome and Introduction to GHS Miguela A. Caniza, MD, MPH, St Jude Children’s Research Hospital |
8:05 – 9:00 AM | Luminaries in Global Health What About the Kids? Improving Outcomes for Children Living With or Exposed to HIV and Lessons Along the Way Pediatric pandemics: Case study of global HIV from 1981-2022 Moderator: Jimmy Carlucci, MD, MPH, Indiana University School of Medicine |
9:00 – 9:15 AM | Q & A with Luminaries Moderator: Jimmy Carlucci, MD, MPH, Indiana University School of Medicine |
9:15 – 9:30 AM | BREAK |
9:30 – 10:30 AM | Poster Session Rapid Fire Abstract Presentations with Professors |
10:30 – 10:40 AM | BREAK |
10:40 AM – 12:00 PM | Global Network Session Moderator: Elizabeth Schlaudecker, MD, MPH, Cincinnati Children's Hospital Medical Center
|
12:00 pm. | Closing Remarks |